Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Multiparametric immune profiling in HPV– oral squamous cell cancer
Zipei Feng, … , Barbara Seliger, Bernard A. Fox
Zipei Feng, … , Barbara Seliger, Bernard A. Fox
Published July 20, 2017
Citation Information: JCI Insight. 2017;2(14):e93652. https://doi.org/10.1172/jci.insight.93652.
View: Text | PDF
Research Article Immunology Oncology

Multiparametric immune profiling in HPV– oral squamous cell cancer

  • Text
  • PDF
Abstract

Evaluation of T lymphocyte frequency provides prognostic information for patients with oral squamous cell cancer (OSCC). However, the effect of simultaneously evaluating T cell frequency and assessing suppressive elements and defects in antigen-processing machinery (APM) has not been clarified. Simultaneous characterization of CD3+, CD8+, FoxP3+, CD163+, and PD-L1+ cells using multispectral imaging was performed on sections from 119 patients with HPV– OSCC. Expression of β2-microglobulin, MHC class I heavy chain, and large multifunctional peptidase 10 was quantified, and all data were correlated with patient outcome. We found that, consistent with previous reports, high numbers of CD8+ T cells at the invasive margin correlated significantly with prolonged overall survival (OS), while the number of FoxP3+ or PD-L1+ cells did not. Compiling the number of FoxP3+ or PD-L1+ cells within 30 μm of CD8+ T cells identified a significant association with a high number of suppressive elements close to CD8+ T cells and reduced OS. Integrating this information into a cumulative suppression index (CSI) increased correlation with OS. Incorporating tumor expression levels of APM components with CSI further improved prognostic power. This multiparametric immune profiling may be useful for stratifying patients with OSCC for clinical trials.

Authors

Zipei Feng, Daniel Bethmann, Matthias Kappler, Carmen Ballesteros-Merino, Alexander Eckert, R. Bryan Bell, Allen Cheng, Tuan Bui, Rom Leidner, Walter J. Urba, Kent Johnson, Clifford Hoyt, Carlo B. Bifulco, Juergen Bukur, Claudia Wickenhauser, Barbara Seliger, Bernard A. Fox

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2009 Total
Citations: 7 11 13 11 20 13 12 16 1 1 105
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2018 (16)

Title and authors Publication Year
Spatial and phenotypic immune profiling of metastatic colon cancer
Jenny Lazarus, Tomek Maj, J. Joshua Smith, Mirna Perusina Lanfranca, Arvind Rao, Michael D'Angelica, Lawrence Delrosario, Alexander Girgis, Casey Schukow, Jinru Shia, Ilona Kryczek, Jiaqi Shi, Isaac Wasserman, Howard Crawford, Hari Nathan, Marina Pasca di Magliano, Weiping Zou, Timothy L Frankel
JCI Insight 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
PA Ascierto, J Brugarolas, L Buonaguro, LH Butterfield, D Carbone, B Daniele, R Ferris, BA Fox, J Galon, C Gridelli, HL Kaufman, CA Klebanoff, I Melero, P Nathan, CM Paulos, M Ruella, R Sullivan, H Zarour, I Puzanov
Journal for ImmunoTherapy of Cancer 2018
Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
SF Gameiro, F Ghasemi, JW Barrett, J Koropatnick, AC Nichols, JS Mymryk, SM Vareki
OncoImmunology 2018
On the Road to Immunotherapy—Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor Antibodies
FJ Ward, LN Dahal, R Abu-Eid
Frontiers in immunology 2018
Machine Learning Methods for Histopathological Image Analysis
D Komura, S Ishikawa
Computational and Structural Biotechnology Journal 2018
Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis
KE Steele, TH Tan, R Korn, K Dacosta, C Brown, M Kuziora, J Zimmermann, B Laffin, M Widmaier, L Rognoni, R Cardenes, K Schneider, A Boutrin, P Martin, J Zha, T Wiestler
Journal for ImmunoTherapy of Cancer 2018
The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma
SR Ottenhof, RS Djajadiningrat, HH Thygesen, PJ Jakobs, K Jóźwiak, AM Heeren, J de Jong, J Sanders, S Horenblas, ES Jordanova
Frontiers in immunology 2018
Quantitative Analysis of Immune Infiltrates in Primary Melanoma
RD Gartrell, DK Marks, TD Hart, Li, DR Davari, A Wu, Z Blake, Y Lu, KN Askin, A Monod, CL Esancy, EC Stack, DT Jia, PM Armenta, Y Fu, D Izaki, B Taback, R Rabadan, HL Kaufman, CG Drake, BA Horst, YM Saenger
Cancer immunology research 2018
Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma
DJ Hartman, F Ahmad, RE Ferris, D Rimm, L Pantanowitz
Oral Oncology 2018
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
NA Giraldo, P Nguyen, EL Engle, GJ Kaunitz, TR Cottrell, S Berry, B Green, A Soni, JD Cuda, JE Stein, JC Sunshine, F Succaria, H Xu, A Ogurtsova, L Danilova, CD Church, NJ Miller, S Fling, L Lundgren, N Ramchurren, JH Yearley, EJ Lipson, M Cheever, RA Anders, PT Nghiem, SL Topalian, JM Taube
Journal for ImmunoTherapy of Cancer 2018
Deciphering the Role of Regulatory CD4 T Cells in Oral and Oropharyngeal Cancer: A Systematic Review
C O'Higgins, FJ Ward, RA Eid
Frontiers in Oncology 2018
Role of the immunosuppressive microenvironment in immunotherapy
GW Tormoen, MR Crittenden, MJ Gough
Advances in Radiation Oncology 2018
Precision immunoprofiling by image analysis and artificial intelligence
VH Koelzer, K Sirinukunwattana, J Rittscher, KD Mertz
Virchows Archiv 2018
HLA class II expression on tumor cells and low numbers of tumor‐associated macrophages predict clinical outcome in oropharyngeal cancer
B Cioni, ES Jordanova, E Hooijberg, R Linden, RX Menezes, K Tan, S Willems, JB Elbers, A Broeks, AM Bergman, CL Zuur, JP de Boer
Head & neck 2018
Implantable biomaterials to provide local immunotherapy following surgical resection
MJ Gough, JR Baird, RB Bell
Oncotarget 2018
Novel frontiers in detecting cancer metastasis
SP Leong, C Ballesteros-Merino, SM Jensen, S Marwitz, C Bifulco, BA Fox, M Skoberne
Clinical & Experimental Metastasis 2018

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts